<SEC-DOCUMENT>0001193125-24-149142.txt : 20240529
<SEC-HEADER>0001193125-24-149142.hdr.sgml : 20240529
<ACCEPTANCE-DATETIME>20240529160631
ACCESSION NUMBER:		0001193125-24-149142
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240523
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240529
DATE AS OF CHANGE:		20240529

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DELCATH SYSTEMS, INC.
		CENTRAL INDEX KEY:			0000872912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				061245881
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16133
		FILM NUMBER:		24998358

	BUSINESS ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804
		BUSINESS PHONE:		(518) 743-8892

	MAIL ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DELCATH SYSTEMS INC
		DATE OF NAME CHANGE:	19990607
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d837937d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dcth="http://www.delcath.com/20240523" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2024-05-23_to_2024-05-23">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-458">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-23_to_2024-05-23">0000872912</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="dcth-20240523.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-23_to_2024-05-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-23</xbrli:startDate> <xbrli:endDate>2024-05-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-469">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt:datemonthdayyearen" id="ixv-470">May&#160;23, 2024</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-471">Delcath Systems, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-472">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-473">001-16133</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-474">06-1245881</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:33%"/>
<td style="vertical-align:bottom"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-475">566 Queensbury Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-476">Queensbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-477">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-478">12804</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-479">(212)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-480">489-2100</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-481">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-482">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-483">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-484">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities pursuant to Section&#160;12 (b) of the Act:</p> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">Securities registered pursuant to Section 12(b) of the Act: </span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title&#160;of&#160;Each&#160;Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;Each&#160;Exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on&#160;Which&#160;Registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-485">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-486">DCTH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-487">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 5.07 of this Current Report on Form <span style="white-space:nowrap">8-K</span> under the heading &#8220;Appointment of Director/Nasdaq Listing Rule 5605(c)(2)&#8221; as it relates to the audit committee (&#8220;Audit Committee&#8221;) of the board of directors (the &#8220;Board&#8221;) of Delcath Systems, Inc. (the &#8220;Company&#8221;) is hereby incorporated by reference in this Item 3.01. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Omnibus Equity Incentive Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the 2024 annual meeting of stockholders held on May&#160;23, 2024 (the &#8220;Annual Meeting&#8221;), the stockholders of the Company approved an amendment to the Company&#8217;s 2020 Omnibus Equity Incentive Plan (the &#8220;2020 EIP&#8221;) to increase by 2,000,000 the number of shares of the Company&#8217;s common stock, $0.01 par value (the &#8220;Common Stock&#8221;) available thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A more detailed summary of the material features of the 2020 EIP, as amended, including the terms of stock option grants thereunder, is set forth in the Company&#8217;s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April&#160;12, 2024 (the &#8220;2024 Proxy Statement&#8221;). That summary and the foregoing description are qualified in their entirety by reference to the text of the 2020 EIP, as amended, which is attached as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Director/Nasdaq Listing Rule 5605(c)(2) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the voting on Proposal 1 (as listed below in Item 5.07) at the Annual Meeting on May&#160;23, 2024, Roger Stoll&#8217;s previously announced retirement from the Board took effect. On March&#160;24, 2024, the Company notified The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) of the retirement of Roger Stoll from the Board and the Audit Committee. With Dr.&#160;Stoll&#8217;s retirement the Audit Committee currently is comprised of only two qualified Directors. Pursuant to Nasdaq Listing Rule 5605(c)(2), the Audit Committee must be comprised of at least three qualified Directors. On May 29, 2024, the Company received notice from Nasdaq confirming that the Company was no longer in compliance with such Nasdaq Listing Rule. The Company intends to fill the vacancy on the Audit Committee as expeditiously as possible. The Company is entitled to a cure period to regain compliance with Nasdaq Listing Rule 5605(c)(2)(A) until the earlier of the Company&#8217;s next annual meeting or May&#160;23, 2025. The Company will regain compliance with the audit committee composition requirements of Nasdaq Listing Rule 5605(c)(2)(A) by the end of the cure period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, in connection with Roger Stoll&#8217;s retirement from the Company&#8217;s Board, on May&#160;23, 2024, the Company appointed Bridget Martell, M.A. M.D., as a Class&#160;III Director on the Company&#8217;s Board, commencing on May&#160;23, 2024 and continuing until her term on the Board expires at the Company&#8217;s 2027 Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At this time, Dr.&#160;Martell has not been named to any committees of the Board. There are no arrangements or understandings between Dr.&#160;Martell and any other persons pursuant to which she was elected as a director, and there are no transactions between Dr.&#160;Martell and the Company that would be required to be reported under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Company&#8217;s press release related to Dr.&#160;Martell&#8217;s appointment&#160;to the Board&#160;is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s stockholders voted on four proposals, each of which is described in more detail in the 2024 Proxy Statement. Of the 27,433,579 shares of the Common Stock outstanding and convertible preferred stock eligible to vote as of the record date, 18,089,113 shares, or approximately 65.94%, were present or represented by proxy at the Annual Meeting. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a brief description of each matter voted upon and the certified results, including the number of votes cast for and against each matter and, if applicable, the number of votes withheld, abstentions and broker <span style="white-space:nowrap">non-votes</span> with respect to each such matter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Proposal 1.</span> Stockholders elected the following nominee to serve as a Class&#160;III director on the Board until the Company&#8217;s 2027 Annual Meeting or until his successor has been duly elected and qualified. The voting results for such nominee was as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:62%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Director&#160;Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Votes&#160;For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Votes&#160;Withheld</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Broker&#160;Non-<br/>Votes</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Salamon</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,411,468</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,555,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Proposal 2.</span> Stockholders approved the amendment to the 2020 EIP to increase by 2,000,000 the number of shares of Common Stock available under thereunder. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Abstentions</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Broker&#160;Non-<br/>Votes</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">13,022,078</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">498,186</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">13,501</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">4,555,348</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Proposal 3.</span> Stockholders ratified the selection by the Audit Committee of the Board of Marcum, LLP as the Company&#8217;s independent registered public accounting firm for its fiscal year ending December&#160;31, 2024. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Abstentions</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Broker&#160;Non-<br/>Votes</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">17,870,451</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">199,555</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">19,107</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">N/A</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Proposal 4.</span> Stockholders approved a <span style="white-space:nowrap">non-binding</span> advisory vote on the compensation of the Company&#8217;s named executive officers. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Votes&#160;Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Abstentions</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Broker&#160;Non-<br/>Votes</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top" align="center">13,070,270</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">432,115</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">31,380</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">4,555,348</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d837937dex101.htm">2020 Omnibus Equity Incentive Plan, as amended</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d837937dex991.htm">Press Release of Delcath Systems, Inc. dated May&#160;28, 2024</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May 29, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">DELCATH SYSTEMS, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gerard Michel</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Gerard Michel</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d837937dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 OMNIBUS EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(As adopted by Board of Directors on September&nbsp;30, 2020 and approved by stockholders on November&nbsp;23, 2020) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(As amended by the Board of Directors on March&nbsp;30, 2021 and approved by stockholders on May&nbsp;6, 2021) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(As subsequently amended by the Board of Directors on April&nbsp;17, 2023 and approved by stockholders on June&nbsp;12, 2023) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(As subsequently amended by the Board of Directors on March&nbsp;27, 2024, and approved by stockholders on May&nbsp;23, 2024) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Purpose</U></B>. The purpose of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (the
&#147;<U>Plan</U>&#148;) is to align the interests of selected Employees, <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors and Consultants with those of Delcath Systems, Inc.&#146;s (the &#147;<U>Company</U>&#148;) stockholders by
providing such individuals with long-term incentive compensation opportunities tied to the performance of the Company&#146;s Common Stock. The Plan is intended to advance the interests of the Company and its stockholders by attracting, retaining and
motivating key personnel upon whose judgment, initiative and effort the successful conduct of the Company&#146;s business is largely dependent. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The Plan was originally adopted by the Board of Directors on September&nbsp;30, 2020 and approved by the stockholders of the Company on
November&nbsp;23, 2020. The Plan was subsequently amended by the Board of Directors on March&nbsp;30, 2021 and approved by stockholders of the Company on May&nbsp;6, 2021 <U>and subsequently amended by the Board of Directors on
April</U><U></U><U>&nbsp;17, 2023 and approved by stockholders of the Company on June</U><U></U><U>&nbsp;12, 2023</U>.<U> On March</U><U></U><U>&nbsp;27, 2024, </U>the Board approved an amendment of the Plan in the form set forth herein (the
&#147;Amended Plan&#148;), subject to, and to be effective upon, the approval of the stockholders of the Company in accordance with the requirements of the laws of the State of Delaware at the Company&#146;s <U>2024</U> annual stockholders&#146;
meeting held on <U>May</U><U></U><U>&nbsp;23, 2024. If the Amended Plan is not so approved by the stockholders, all provisions of the Plan shall remain effective.</U> </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Definitions</U></B>. Certain terms used in the Plan have the meanings set forth below (capitalized
terms used in the Plan that are not defined below have the meanings set forth elsewhere in the Plan): </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means any Subsidiary and any other corporation or other entity (including, but not limited to, partnerships and
joint ventures) controlling, controlled by, or under common control with, the Company. For this purpose, &#147;control&#148; (including, with correlative meaning, the terms &#147;controlled by&#148; and &#147;under common control with&#148;), as
applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting or other securities, by contract or otherwise.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Law</U>&#148; means any applicable securities, federal, state, foreign, material local or municipal or other law,
statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by
or under the authority of any governmental or regulatory body or self-regulatory organization (including the Nasdaq Stock Market, the New York Stock Exchange and the Financial Industry Regulatory Authority). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Award</U>&#148; means an award under the Plan, including any Incentive Stock Option, a
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option, Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Award, an Other Stock-Based Award or a Cash Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Award Agreement</U>&#148; means the written agreement entered into between the Participant and the Company setting forth the terms and
conditions applicable to an Award, as provided under Section&nbsp;5(c). An Award Agreement may, in the discretion of the Committee, be transmitted electronically to any Participant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Price</U>&#148; means the price per share of Common Stock subject to a Stock Appreciation Right at which the Stock Appreciation
Right may be exercised or settled.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Company&#146;s Board of Directors, as constituted from time to time.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash Award</U>&#148; means an award denominated in cash that is granted pursuant to Section&nbsp;11. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148;, with respect to any Employee or Consultant, unless the applicable Award Agreement provides otherwise, shall have the
meaning given to such term in any employment or other written agreement between such Participant and the Company or Affiliate, as applicable, or, in the event that such term is not defined in such agreement or in the absence of any such agreement,
shall mean the occurrence of any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s willful failure to perform his or her duties and responsibilities to the Company or an
Affiliate, or refusal to perform any lawful and reasonable directive of the Company or an Affiliate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s gross negligence or willful misconduct in the performance of his or her duties for the
Company or an Affiliate; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s commission of any act of fraud, embezzlement, dishonesty, moral turpitude,
misappropriation of funds, breach of fiduciary duty, duty of loyalty and fidelity or other willful misconduct with respect to the Company or an Affiliate, or any act, whether or not related to the performance of the Participant&#146;s Service, that
affects the Company&#146;s or any Affiliate&#146;s reputation in a manner that may reasonably be expected to have a material adverse effect on the business, prospects, assets (including intangible assets), liabilities, financial condition, property
or results of operation of the Company or any Affiliate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s unauthorized use or disclosure of any proprietary information or trade secrets of the
Company or any Affiliate or any other party to whom the Participant owes an obligation of nondisclosure as a result of the Participant&#146;s relationship with the Company or any Affiliate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s breach of any of his or her obligations under any written agreement or covenant with, or
any material policy of, the Company or any Affiliate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s indictment or conviction of or plea of nolo contendere to a felony or crime of moral
turpitude; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s debarment, exclusion or disqualification by any government regulator or government
agency from participating in the business of the Company or any Affiliate; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Participant&#146;s exhibition of a standard of behavior within the scope of or related to the
Participant&#146;s employment, or is a violation of the Company&#146;s code of conduct, that is disruptive to the orderly conduct of the Company&#146;s or its Affiliates&#146; business operations (including, without limitation, substance abuse,
sexual harassment or sexual misconduct, or other unlawful harassment or retaliation). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cause</U>&#148;, with
respect to any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, unless the applicable Award Agreement provides otherwise, means a determination by a majority of the disinterested Directors that the
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director has engaged in any of the following: (i)&nbsp;malfeasance while in office; (ii)&nbsp;gross negligence, willful misconduct or neglect with respect to the Company or any Affiliate;
(iii)&nbsp;false or fraudulent misrepresentation in connection with the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s appointment; or (iv)&nbsp;conversion of corporate funds. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, references to the Company and Affiliate in the foregoing definitions of &#147;Cause&#148; shall include the
successor to either as may be appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change in Control</U>&#148; means the date of the occurrence of any of the following
events, provided that the event constitutes a &#147;change in control event&#148; within the meaning of Section&nbsp;409A of the Code: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The consummation of any consolidation or merger of the Company with any other entity, other than a transaction
which would result in the voting power of the securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its
parent) at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such consolidation or merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any one Person, or more than one Person acting as a group, acquires ownership of the stock of the Company that,
together with the stock held by such Person or group, constitutes more than 50% of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection, (A)&nbsp;the acquisition of additional stock by any one
Person or group, who is considered to own more than 50% of the total voting power of the stock of the Company will not be considered a Change in Control, and (B)&nbsp;if the stockholders of the Company immediately before such change in ownership
continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#146;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial
ownership of 50% or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control under this subsection (ii). For this purpose, indirect beneficial
ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more
subsidiary corporations or other business entities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A majority of the Directors is replaced during any <FONT STYLE="white-space:nowrap">12-month</FONT> period by
Directors whose appointment or election is not endorsed by a majority of the Directors prior to the date of the appointment or election; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any one Person, or more than one Person acting as a group, acquires (or has acquired during the <FONT
STYLE="white-space:nowrap">12-month</FONT> period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market
value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iv), the following will not constitute a change in the ownership of a substantial portion of
the Company&#146;s assets: (A)&nbsp;a transfer to an entity that is controlled by the Company&#146;s stockholders immediately after the transfer, or (B)&nbsp;a transfer of assets by the Company to: (1)&nbsp;a stockholder of the Company (immediately
before the asset transfer) in exchange for or with respect to the Company&#146;s stock, (2)&nbsp;an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3)&nbsp;a Person, that owns,
directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the Company, or (4)&nbsp;an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a Person
described in subsection (3)&nbsp;above. For purposes of this subsection (iv), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated
with such assets. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, Persons will be considered to be acting as a group if they
are owners of an entity that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, as the same may be
amended from time to time and any successor statute. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Committee</U>&#148; means the committee of the Board appointed by the Board
to administer the Plan, pursuant to Section&nbsp;3, which, unless otherwise determined by the Board, shall be the Compensation and Stock Option Committee. In the absence of any such Committee, any action permitted or required to be taken hereunder
by the Committee shall be deemed to refer to the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the Company&#146;s common stock, par value
$0.01 per share, or such other securities of the Company as may be designated by the Committee in substitution thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consultant</U>&#148; means any Person who provides consulting or other services to the Company or any Affiliate and who is
(i)&nbsp;neither an Employee nor a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director and (ii)&nbsp;may be offered securities registrable pursuant to a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the
Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disability</U>&#148; means (a)&nbsp;in the case of Incentive Stock Options, total and permanent disability as defined in
Section&nbsp;22(e)(3) of the Code, and (b)&nbsp;in the case of other Awards, unless the applicable Award Agreement provides otherwise, that the Participant is unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment (and considered &#147;disabled&#148; within the meaning of Section&nbsp;409A of the Code). The determination of whether an individual has a Disability shall be determined under procedures established by the
Committee, which shall be final, conclusive and binding. Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option, the Committee may rely on any determination that a Participant is
disabled for purposes of benefits under any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Equivalent Right</U>&#148; means the right of a Participant, granted pursuant to Section&nbsp;9 in connection with the
Restricted Stock Unit Award, to receive a credit for the account of such Participant in an amount equal to cash or stock dividends or other distributions paid by the Company in respect of one share of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; means the original date of adoption of the Plan by the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Eligible Person</U>&#148; means any of the following: (i)&nbsp;any Employee, Consultant, or
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director or (ii)&nbsp;any individual to whom the Company or any Affiliate has extended a formal offer of employment, so long as the grant of any Award shall not become effective until such
individual commences such employment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employee</U>&#148; means an individual, including, without limitation, any Officer and
Director, who is a common law employee of the Company or an Affiliate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act
of 1934, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exercise Price</U>&#148; means the price at which a share of Common Stock subject to an Option may be
purchased upon the exercise of the Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; means, as of any date, the value of the Common Stock
determined as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Common Stock is publicly traded and is then listed on a national securities exchange, its closing price
on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in <I>The Wall Street Journal</I> or such other source as the Committee deems reliable (subject to
compliance with Applicable Law, including Section&nbsp;409A of the Code); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities
exchange, the average of the closing bid and asked prices on the date of determination as reported in The <I>Wall Street Journal</I> or such other source as the Committee deems reliable; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If none of the foregoing is applicable, by the Board or the Committee in good faith (and in accordance with
Section&nbsp;409A of the Code, as applicable), which such decision shall be final, conclusive and binding. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Grant Date</U>&#148; means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting
an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution or action, then such date as set forth in such resolution or action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incentive Stock Option</U>&#148; means an Option that is intended to meet the requirements of Section&nbsp;422 of the Code and is
designated as an Incentive Stock Option. To the extent that any Option is not designated as an Incentive Stock Option, or even if so designated does not qualify as an Incentive Stock Option at or subsequent to its Grant Date, it shall constitute a <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>&#148;
means a Director who is not an Employee, and who satisfies the requirements of a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the meaning of Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option</U>&#148; means an
Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; means a person who is an officer of the Company within the
meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option</U>&#148; means the
right to purchase, at the price and for the term fixed by the Committee in accordance with Section&nbsp;6, and subject to such other limitations and restrictions in the Plan and the applicable Award Agreement, a number of shares of Common Stock
determined by the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Other Stock-Based Award</U>&#148; means an Award that is not an Option, Stock Appreciation Right,
Restricted Stock Award, Restricted Stock Unit Award or Cash Award, and that is granted under Section&nbsp;11 and is payable by delivery of Common Stock and/or which is measured by reference to the value of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Participant</U>&#148; means an Eligible Person to whom the Committee has granted an Award under the Plan (or, if applicable, such
other Person who holds an outstanding Award). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Award</U>&#148; means an award that may vest or may become eligible to
vest contingent upon the attainment during a Performance Period of certain Performance Goals and which is granted pursuant to the terms of Section&nbsp;10. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Goal</U>&#148; means one or more goals as may be established by the Committee that must be met by the end of a given
Performance Period as a contingency for a given Award to vest and/or become exercisable, settled or payable, or to otherwise determine the numbers of shares of Common Stock or stock-denominated units that are earned under an Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Performance Period</U>&#148; means one or more periods of time, as the Committee may select, over which the attainment of one or more
Performance Goals will be measured for the purpose of determining a Participant&#146;s right to vesting, exercisability, settlement or payment of an Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, a partnership, a corporation, a limited liability company, an association, a joint share
company, a trust, a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Stock Award</U>&#148; means a grant of shares of Common Stock under Section&nbsp;8 that are issued subject to vesting and
transfer restrictions and such other conditions as are set forth in the Plan and the applicable Award Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Stock
Unit Award</U>&#148; means an Award of Restricted Stock Units under Section&nbsp;9. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT></U>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to
time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended from time to time or any successor statute. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Service</U>&#148; means, as applicable, a Participant&#146;s service with the Company or an Affiliate, as an Employee, <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director or Consultant. For purposes of the Plan, a Participant&#146;s Service shall not be deemed to have been terminated merely because of a change in the capacity in which the Participant renders
service to the Company or an Affiliate as an Employee, Consultant or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director or merely because of a transfer of the Participant&#146;s Service between the Company and/or Affiliates (except as may
be required for compliance with Section&nbsp;409A of the Code). The Committee, in its sole discretion, may determine whether a Company transaction, such as a sale or <FONT STYLE="white-space:nowrap">spin-off</FONT> of a division or subsidiary that
employs a Participant, shall be deemed to result in a termination of Service for purposes of affected Awards, and such decision shall be final, conclusive and binding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stock Appreciation Right</U>&#148; means a contractual right granted under Section&nbsp;7 entitling the holder of such right to
receive, subject to limitation and restrictions in the Plan and applicable Award Agreement, the appreciation in value of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means any entity in which the Company owns at least 50% of the combined voting power of all classes of equity
entitled to vote or at least 50% of the combined value of all classes of equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ten Percent Stockholder</U>&#148; means an
Employee who, at the time an Option is granted, owns either directly or indirectly (taking into account the attribution rules contained in Section&nbsp;424(d) of the Code), stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company or any Affiliate. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Administration of the Plan</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>General</U>. The Plan shall be administered by the Committee (or the Board if no Committee has been
appointed). The Committee shall have the power and authority to (i)&nbsp;prescribe, amend and rescind rules and procedures governing the administration of the Plan; (ii)&nbsp;determine and designate from time to time each Eligible Person to whom an
Award will be granted and the type of Award to be granted; (iii)&nbsp;determine the number of shares of Common Stock subject to each Award and the Grant Date of each Award; (iv)&nbsp;prescribe the terms of each Award, including, without limitation,
the time or times when, and the manner and conditions upon which, each Award shall vest, become exercisable, be settled and/or expire, the Exercise Price or Base Price of each Award (as may be applicable), and the form of payment made in settlement
of each Award; (v)&nbsp;specify the terms of the Award Agreement relating to each Award; (vi)&nbsp;determine or impose other conditions to the receipt of shares of Common Stock subject to an Award, as it may deem
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
appropriate, including but not limited to, cash payments; (vii)&nbsp;interpret the terms of the Plan and each Award Agreement and the rules of procedures established by the Committee under the
Plan; (viii)&nbsp;determine the rights of all Persons under the Plan; (ix)&nbsp;correct any defect or omission or reconcile any inconsistency in the Plan or in any Award Agreement; (x)&nbsp;make all determinations relating to the Service of a
Participant; (xi)&nbsp;grant waivers of any conditions of the Plan or any Award Agreement, subject to Applicable Law; and (xii)&nbsp;make all other determinations and take all other actions necessary or advisable for the implementation and
administration of the Plan. In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting of dividends under an Award, the Committee shall have the discretionary authority to round such fractional share or unit
to the nearest higher whole share or unit, or convert such fractional share or unit into a right to receive a cash payment (unless determined otherwise by the Committee, such fractional share or unit shall be rounded to the nearest higher whole
share or unit). All actions, decisions and interpretations of the Committee, the Board and any delegate of the Committee or Board under the Plan or any Award Agreement shall be final, binding, conclusive and
<FONT STYLE="white-space:nowrap">non-appealable</FONT> on all Persons, and shall be given the maximum deference permitted by law. The Committee&#146;s and the Board&#146;s determinations under the Plan (including, without limitation, determinations
of the persons to receive Awards, the form, amount and timing of such Awards, the terms and provisions of such Awards and the Award Agreements evidencing such Awards) need not be uniform and may be made by the Committee or the Board selectively
among Persons who receive, or are eligible to receive, Awards under the Plan, whether or not such Persons are similarly situated. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Composition of the Committee</U>. Except as otherwise determined by the Board, the Committee shall
consist of two or more Directors appointed to such committee from time to time by the Board. To the extent deemed necessary or appropriate by the Board, the Committee shall consist solely of at least two Directors who are <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors and are &#147;independent directors&#148; under any applicable exchange requirements. The Board shall have discretion to determine whether or not it intends to comply with the exemption
requirements of Rule <FONT STYLE="white-space:nowrap">16b-3;</FONT> however, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section&nbsp;16 of the Exchange Act, the Committee shall be a
compensation committee of the Board that at all times consists solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. Nothing herein shall create an inference that an Award is not validly granted under the Plan in the
event Awards are granted under the Plan by a committee of the Board that does not at all times consist solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Delegation of Authority</U>. The Board or the Committee may delegate to a committee of one or more
Directors and/or Officers who are not <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors the authority to grant Awards to Eligible Persons who are not then subject to Section&nbsp;16 of the Exchange Act. In the event of such delegation
of authority, all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with such delegation by treating any reference to the Committee as a reference to the committee or Officers to whom such delegation has
been made. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Limited Liability; Indemnification</U>. In addition to such other rights of indemnification as they may have
as Directors or members of the Committee, and to the maximum extent allowed by the Company&#146;s charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> and Applicable Laws, the Committee shall be indemnified by the Company against the reasonable
expenses, including attorney&#146;s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act under or in
connection with the Plan or any Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (<I>provided, however</I>, that the settlement has been approved by the Company, which approval shall not be
unreasonably withheld) or paid by the Committee in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such Committee did not act
in good faith and in a manner which such person reasonably believed to be in the best interests of the Company, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was unlawful; <I>provided, however</I>,
that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Shares Subject to the Plan</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Aggregate Limit</U>. Subject to adjustment as set forth in <U>Section</U><U></U><U>&nbsp;4(d)</U>, the total
number of shares of Common Stock reserved and available for grant and issuance pursuant to Awards under the Plan is equal to <U>7,125,000</U>&nbsp;shares (the &#147;<U>Share Reserve</U>&#148;), the full amount of which may be issued under the Plan
through the exercise of Incentive Stock Options. For purposes of counting shares against the Share Reserve, Awards denominated in shares of Common Stock and other Awards that may be exercised for, settled in or convertible into shares of Common
Stock will be counted against the Plan reserve on the date of grant of the Award based on the maximum number of shares that may be issued pursuant to the Award, as determined by the Committee. Shares of Common Stock delivered under the Plan shall
consist of authorized and unissued shares, treasury shares, forfeited shares and/or shares reacquired by the Company in any manner. As of the Effective Date, no further awards shall be made under the Company&#146;s 2019 Equity Incentive Plan or any
other prior equity incentive plans of the Company (but such plans shall remain in effect as to awards made thereunder that are still outstanding as of the Effective Date). </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Individual Limits.</U> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Participants other than <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</U>. Subject to
adjustment under Section&nbsp;4(d), (A) the maximum number of shares of Common Stock underlying Options and Stock Appreciation Rights that may be granted under the Plan during any calendar year to any one Participant (other than a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be 500,000 shares; (B)&nbsp;the maximum number of shares of Common Stock subject to Restricted Stock Awards, awards of Restricted Stock Units and Other Stock Based Awards that may be
granted under the Plan during any calendar year to any one Participant (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be 500,000 (where the number of shares earned is dependent on the level of attainment of
Performance Goals under a Performance Award, the number of shares counted shall be the number that may be earned at maximum performance); (C) the maximum amount of a Cash Award that may be paid pursuant to <U>Section</U><U></U><U>&nbsp;11</U> in any
calendar year to any Participant (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall be $3,000,000. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</U>. In any director year (as described
below), no <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may receive Awards under the Plan that, when combined with cash compensation received for his or her service as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director
during such director year, exceed an aggregate value of $750,000 (with value of each equity award based on its grant date fair value, determined in accordance with U.S. generally accepted accounting principles). Any cash compensation paid or Awards
granted to an individual for his or her service as an Employee, or for his or her services as a Consultant (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director), will not count for purposes of the limitation under this
Section. For purposes of the foregoing, a &#147;director year&#148; shall mean the approximate <FONT STYLE="white-space:nowrap">one-year</FONT> period beginning on the date of a regular annual meeting of the Company&#146;s stockholders and ending on
the date of the next regular annual meeting of the Company&#146;s stockholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Returned Shares</U>. Any shares of Common Stock subject to an outstanding Award or any portion
thereof granted under the Plan will be returned to the Share Reserve and will be available for issuance in connection with subsequent Awards under the Plan to the extent such shares (or the Awards covering such shares)&nbsp;(i) are cancelled,
forfeited or settled in cash; (ii)&nbsp;expire by their terms at any time; or (iii)&nbsp;are reacquired by the Company pursuant to a forfeiture provision. Notwithstanding the foregoing, shares subject to an Award shall not again be made available
for issuance under the Plan if such shares are surrendered or tendered to pay the Exercise Price or Base Price of such Award or any tax withholding obligation arising in connection with vesting, exercise or settlement of such Award.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Adjustments for Changes in Common Stock, Etc</U>. In the event of any change with respect to the
outstanding shares of Common Stock by reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock, or any merger,
reorganization, consolidation, combination, <FONT STYLE="white-space:nowrap">spin-off,</FONT> or other similar corporate change, or any other any relevant change affecting the capitalization of the Company, the Committee shall, in the manner that
it, in its sole discretion, determines is appropriate, cause an equitable adjustment or substitution to be made to (i)&nbsp;the maximum number of shares (or other securities or rights) reserved for issuance and future grant from the Share Reserve,
(ii)&nbsp;the individual award limits set forth in <U>Section</U><U></U><U>&nbsp;4(b)</U>, (iii) the number and kind of shares (or other securities or rights) subject to then outstanding Awards, (iv)&nbsp;the Exercise Price or Base Price with
respect to any Option or Stock Appreciation Right, (v)&nbsp;the Performance Goals applicable to any Award and (vi)&nbsp;any other terms of an Award that are affected by the event. Any such actions shall be taken by the Company in good faith so as to
substantially preserve the value, rights and benefits of any affected Awards. In the case of adjustments made pursuant to this <U>Section</U><U></U><U>&nbsp;4(d)</U>, unless the Committee specifically determines that such adjustment is in the best
interests of the Company or Affiliates, the Committee shall, in the case of Incentive Stock Options, ensure that any adjustments under this <U>Section</U><U></U><U>&nbsp;4(d)</U> will not constitute a modification, extension or renewal of the
Incentive Stock Options within the meaning of Section&nbsp;424(h)(3) of the Code, and in the case of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options and Stock Appreciation Rights, ensure that any adjustments under this
<U>Section</U><U></U><U>&nbsp;4(d)</U> will not constitute a modification of such <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options within the meaning of Section&nbsp;409A of the Code. Any adjustments made under this Section&nbsp;4(d)
shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and,
upon notice, such adjustment shall be conclusive and binding for all purposes. In addition, in connection with any of the events described above, the Committee, in its sole discretion, and subject to compliance with Section&nbsp;409A of the Code may
provide that each Award then-outstanding shall terminate in exchange for an equitable payment as determined by the Committee in good faith, which, in the case of Options and Stock Appreciation Rights, may include a cash payment to the extent of the
excess, if any, of the then-Fair Market Value of a share of Common Stock subject to the Award, over the Exercise Price or Base Price per share of Common Stock subject to the Award, and in the event that there is no such excess, a payment of zero.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Substitute Awards</U>. Awards may, in the sole discretion of the Committee, be granted under the Plan in
assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or an Affiliate or with which the Company or Affiliate combines after the Effective Date (&#147;<U>Substitute Awards</U>&#148;). To the
extent permitted by Applicable Law, shares of Common Stock subject to Substitute Awards shall not be counted against the Share Reserve; provided, that, Substitute Awards issued in connection with the assumption of, or in substitution for,
outstanding options intended to qualify as &#147;incentive stock options&#148; within the meaning of Section&nbsp;422 of the Code shall be counted against the share limit applicable to Incentive Stock Options. Notwithstanding any other provision of
the Plan, the terms of Substitute Awards may vary from the terms set forth in the Plan to the extent the Committee deems appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Eligibility and Awards</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Designation of Participants</U>. Any Eligible Person may be selected by the Committee to receive an Award
and become a Participant under the Plan in accordance with the Committee&#146;s authority under Section&nbsp;3. In selecting Eligible Persons to be Participants, and in determining the type and amount of Awards to be granted under the Plan, the
Committee shall consider any and all factors that it deems relevant or appropriate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Determination of Awards</U>. The Committee shall determine the terms and conditions of all Awards granted to
Participants in accordance with its authority under Section&nbsp;3 and other terms of the Plan. An Award may consist of one type of right or benefit hereunder or of two or more such rights or benefits granted in tandem. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Award Agreements</U>. Each Award under the Plan shall be evidenced by an Award Agreement in a written or
electronic form approved by the Committee setting forth (as applicable) the number of shares of Common Stock, units or other rights subject to the Award, the Exercise Price, Base Price, or purchase price of the Award, the time or times at which an
Award will become vested, exercisable, settled or payable, the term of the Award and any Performance Goals applicable to the Award. The Award Agreement may also set forth the effect on an Award of a Change in Control or a termination of Service
under certain circumstances. The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and may also set forth other terms and conditions applicable to the Award as
determined by the Committee consistent with the limitations of the Plan. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are specified
in the Plan as being applicable to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B></B><B></B><B></B><B><U>Option Awards</U></B>.<B>&nbsp;</B> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Grant of Options</U>. An Award of an Option may be granted to any Eligible Person selected by the Committee
and shall be evidenced by an Award Agreement setting forth the Exercise Price, the term of the Option, the number of shares of Common Stock to which the Option relates, any conditions to the exercise or vesting of all or a portion of the Option and
such other terms and conditions as the Committee, in its sole discretion, shall determine. The Award Agreement pertaining to an Option shall designate such Option as an Incentive Stock Option or a
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option. In no event shall an Incentive Stock Option be granted to an individual who is not an employee of the Company or of a &#147;subsidiary corporation&#148; or a &#147;parent
corporation,&#148; whether now or hereafter existing, as such terms are defined in Section&nbsp;424(f) of the Code. To the extent the aggregate Fair Market Value (determined as of the time the Option is granted) of the shares of Common Stock with
respect to which an Incentive Stock Option may first become exercisable by a Participant in any one calendar year under the Plan exceeds $100,000, the Option or portions thereof which exceed such limit (according to the order in which they were
granted) shall be treated as <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options. The Company shall have no liability to any Participant, or to any other Person, if an Option (or any portion thereof) that is intended to be an Incentive
Stock Option fails to qualify as an Incentive Stock Option at any time or if an Option (or any portion thereof) is determined to constitute &#147;nonqualified deferred compensation&#148; under Section&nbsp;409A of the Code and the terms of such
Option do not satisfy the requirements of Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Exercise Price</U>. The Exercise Price with respect to shares of Common Stock subject to an Option
shall be determined by the Committee in its sole discretion, provided, however, that the Exercise Price per share shall not be less than 100% (or 110% in the case of an Incentive Stock Option granted to a Ten Percent Stockholder) of the Fair Market
Value of a share of Common Stock on the Grant Date of such Option. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant
to an assumption or substitution for another option in a manner satisfying the provisions of Section&nbsp;424(a) of the Code, and a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option may be granted with an Exercise Price lower than that
set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section&nbsp;409A of the Code. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Term of Option</U>. The Committee shall determine and set forth in an Award Agreement the term during
which an Option may be exercised, provided that in no event shall any Option have a maximum term greater than ten years from the Grant Date (except that the maximum term of an Incentive Stock Option granted to a Ten Percent Stockholder shall be no
more than five years from the Grant Date), or such shorter period as set forth in the Award Agreement. Each Option shall terminate, cease to be exercisable and be forfeited not later than the end of the maximum term specified in the Award Agreement
pertaining to the Option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Vesting and Exercisability of Options</U>. The Committee shall, in its sole discretion, provide in an
Award Agreement the time or times at which, or the conditions upon which, an Option or portion thereof shall become vested and/or exercisable. The Committee may condition the vesting and/or exercisability upon the passage of time (e.g., subject to
the Participant&#146;s continued Service for specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an
Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Option upon a Participant&#146;s termination of Service under specified circumstances or upon the occurrence of
other specified events or conditions. To the extent the vesting requirements of an Option are not satisfied, the Option shall be forfeited. In no event may any Option be exercised for a fraction of a share of Common Stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Termination of Service.</U> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>General</U>. Except as otherwise provided in the applicable Award Agreement or other individual written
agreement between the Participant and the Company, if a Participant&#146;s Service terminates (other than for Cause and other than upon the Participant&#146;s death or Disability), the Participant may exercise his or her Option (to the extent that
the Option was vested and the Participant was entitled to exercise such Option as of the date of the termination of Service) within the period of time ending on the earlier of (A) 90 days following the termination of the Participant&#146;s Service,
and (B)&nbsp;the expiration of the term of the Option as set forth in the Plan or Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Disability of Participant</U>. Except as otherwise provided in the applicable Award Agreement or other
individual written agreement between the Participant and the Company, if a Participant&#146;s Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option (to the extent that the Option was
vested and the Participant was entitled to exercise such Option as of the date of termination of Service), but only within such period of time ending on the earlier of (A)&nbsp;the date 12 months following such termination of Service, and
(B)&nbsp;the expiration of the term of the Option as set forth in the Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Death of Participant.</U> Except as otherwise provided in the applicable Award Agreement or other individual
written agreement between the Participant and the Company, if (A)&nbsp;a Participant&#146;s Service terminates as a result of the Participant&#146;s death, or (B)&nbsp;the Participant dies within the period (if any) specified in the Award Agreement
for exercisability after the termination of the Participant&#146;s Service for a reason other than death, then the Option may be exercised (to the extent the Option was vested and the Participant was entitled to exercise such Option as of the date
of death) by the Participant&#146;s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Participant&#146;s death, but only within the period ending on
the earlier of (A)&nbsp;the date 12 months following the date of death, and (B)&nbsp;the expiration of the term of such Option as set forth in the Award Agreement. If, after the Participant&#146;s death, the Option is not exercised within the
applicable time frame, the Option will terminate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Termination for Cause</U>. Except as provided otherwise in a Participant&#146;s Award Agreement or other
individual written agreement between the Company and a Participant, if a Participant&#146;s Service is terminated by the Company or any Affiliate for Cause, each Option, whether vested or unvested, that is held by such Participant shall terminate,
cease to be exercisable/payable and be forfeited as of the date of such termination of Service. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Exercise of Options; Payment.</U> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice of Exercise</U>. Subject to vesting, exercisability and other restrictions provided for hereunder or
otherwise imposed in accordance herewith, an Option may be exercised, in whole or in part, by a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares of Common Stock
to be purchased. An Option may not be exercised after it is forfeited or otherwise terminated. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Payment of Exercise Price</U>. The aggregate Exercise Price shall be paid in full upon the exercise of the
Option. Payment must be made by one of the following methods: (A)&nbsp;cash or a certified or bank cashier&#146;s check; (B)&nbsp;if and upon the terms approved by the Committee in its sole discretion, by delivery to the Company of previously owned
and vested shares of Common Stock, duly endorsed for transfer to the Company, having an aggregate Fair Market Value on the date of exercise equal to the aggregate Exercise Price due for the number of shares being acquired pursuant to such exercise,
(C)&nbsp;if and upon the terms approved by the Committee in its sole discretion, through the withholding by the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Company of shares of Common Stock otherwise to be received, with such withheld shares of Common Stock having an aggregate Fair Market Value on the date of exercise equal to the aggregate Exercise
Price due for the number of shares being acquired; (D)&nbsp;a &#147;cashless&#148; exercise program established with a broker; (E)&nbsp;by any combination of such methods of payment, or (F)&nbsp;any other method approved by the Committee in its sole
discretion. Unless otherwise specifically provided in the Option, the Exercise Price that is paid by delivery to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock
that have been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period the Common Stock is publicly traded,
an exercise by a Director or Officer that involves or may involve a direct or indirect extension of credit or arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section&nbsp;402(a) of the Sarbanes-Oxley Act
of 2002 shall be prohibited. The Committee may impose limitations and prohibitions on the exercise of Options as it deems appropriate, including, without limitation, any limitation or prohibition designed to avoid accounting consequences which may
result from the use of shares of Common Stock as payment of the aggregate Exercise Price. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">g.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Disqualifying Disposition with respect to Incentive Stock Option</U>. If shares of Common Stock
acquired upon the exercise of an Incentive Stock Option are disposed of by a Participant prior to the expiration of (i)&nbsp;two years from the Grant Date of such Option, or (ii)&nbsp;one year from the date of the transfer of shares to the
Participant pursuant to the exercise of such Option, or in any other &#147;disqualifying disposition&#148; within the meaning of Section&nbsp;422 of the Code, such Participant shall notify the Company in writing as soon as practicable thereafter of
the date and terms of such disposition and, if the Company (or any Affiliate) thereupon has a tax withholding obligation, shall pay to the Company (or such Affiliate) an amount equal to any withholding tax the Company (or such Affiliate) is required
to pay as a result of the disqualifying disposition. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Stock Appreciation Rights</U> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Grant of Stock Appreciation Rights</U>. An Award of a Stock Appreciation Right may be granted to any
Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the Base Price, the term of the Stock Appreciation Right, the number of shares of Common Stock to which the Stock Appreciation Right relates, any
conditions to the exercise of all or a portion of the Stock Appreciation Right and such other terms and conditions as the Committee, in its sole discretion, shall determine. A Stock Appreciation Right may, in the sole discretion of the Committee, be
granted in tandem with an Option, and in such event, shall (i)&nbsp;have a Base Price per share equal to the per share Exercise Price of the Option, (ii)&nbsp;be vested and exercisable at the same time or times that a related Option is vested and
exercisable, and (iii)&nbsp;expire no later than the time at which the related Option expires. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Benefits Upon Exercise</U>. Subject to such terms and conditions as specified in an Award Agreement, a Stock
Appreciation Right shall entitle the Participant to receive a payment, upon exercise or other settlement of the Stock Appreciation Right, of an amount determined by multiplying (i)&nbsp;the excess of the Fair Market Value of each share of Common
Stock covered by the Stock Appreciation Right on the date of exercise or settlement of the Stock Appreciation Right over the Base Price per share of Common Stock covered by the Stock Appreciation Right, by (ii)&nbsp;the number of shares of Common
Stock as to which such Stock Appreciation Right is exercised or settled. Such payment may be in cash, in shares of Common Stock (with or without restriction as to substantial risk of forfeiture and transferability, as determined by the Company in
its sole discretion) valued at their Fair Market Value on the date of exercise or other settlement, or in any combination, as the Committee shall determine in the Award Agreement. Upon exercise of a tandem Stock Appreciation Right, the number of
shares of Common Stock for which any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of Common Stock for which a tandem Stock Appreciation
Right shall be exercisable shall be reduced upon any exercise of any related Option by the number of Shares of Common Stock for which such Option has been exercised. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Base Price</U>. The Base Price per share of Common Stock subject to a Stock Appreciation Right shall
be determined by the Committee in its sole discretion, provided, however, that the Base Price per share shall not be less than 100% of the Fair Market Value of a share of Common Stock on the Grant Date of such Stock Appreciation Right.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Term of Stock Appreciation Right</U>. The Committee shall determine and set forth in an Award
Agreement the term during which a vested Stock Appreciation Right may be exercised or settled, provided that in no event shall any Stock Appreciation Right have a maximum term greater than 10 years from the Grant Date, or such shorter period as set
forth in the Award Agreement. Each Stock Appreciation Right shall terminate, cease to be exercisable/payable and be forfeited, not later than the end of the maximum term specified in the Agreement pertaining to the Stock Appreciation Right.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Vesting and Exercisability of Stock Appreciation Rights</U>. The Committee shall, in its sole
discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, a Stock Appreciation Right or portion thereof shall become vested, exercisable and/or settled. The Committee may condition the vesting and/or
exercisability upon the passage of time (e.g., subject to the Participant&#146;s continued Service for a specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award
Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other written agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Stock Appreciation Right upon a
Participant&#146;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. To the extent the vesting requirements of a Stock Appreciation Right are not satisfied, the Stock Appreciation
Right shall be forfeited. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice of Exercise</U>. Subject to vesting, exercisability and other restrictions provided for hereunder or
otherwise imposed in accordance herewith, a Stock Appreciation Right may be exercised, in whole or in part, by a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares
of Common Stock with respect to which the exercise applies. A Stock Appreciation Right may not be exercised after it is forfeited or otherwise terminated. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Termination of Service</U>. The same rules of Section&nbsp;6(e) that apply to Options regarding termination
of Service shall also apply to Stock Appreciation Rights. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Restricted Stock Awards</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Grant of Restricted Stock</U>. A Restricted Stock Award may be granted to any Eligible Person selected by
the Committee and shall be evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Restricted Stock Award, the payment (if any) required for such shares, the vesting restrictions applicable to such shares
and such other terms and conditions as the Committee, in its sole discretion, shall determine. The Committee may require that certificates representing the shares of Common Stock issued pursuant to a Restricted Stock Award bear a legend making
appropriate reference to the restrictions imposed, and that certificates representing such shares will remain in the physical custody of the Company or an escrow holder until all restrictions are removed or have expired. The Committee may also
require the Participant to execute and deliver to the Company (i)&nbsp;an escrow agreement satisfactory to the Committee, if applicable, and (ii)&nbsp;the appropriate blank stock power with respect to the shares of Common Stock covered by such
agreement. If a Participant fails to execute an agreement evidencing a Restricted Stock Award and, if applicable, an escrow agreement and stock power, the Award shall be null and void. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Vesting of Restricted Stock Awards</U>. The Committee shall, in its sole discretion, provide in an Award
Agreement the time or times at which, or the conditions upon which, a Restricted Stock Award shall vest. The restrictions imposed on shares of Common Stock granted under a Restricted Stock Award shall lapse in accordance with the vesting
requirements specified by the Committee in the Award Agreement. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#146;s continued Service for a specified period) and/or the occurrence of any other
event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of
vesting of a Restricted Stock Award upon a Participant&#146;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. If the vesting requirements applicable to a Restricted Stock Award are
not satisfied, the shares subject to the Award shall automatically be forfeited, the Participant shall assign, transfer, and deliver any certificates evidencing ownership of such shares to the Company, and the Participant shall cease for all
purposes to be a stockholder with respect to such shares. If the Participant paid for such forfeited shares in cash or other tangible consideration, then, unless otherwise provided by the Committee in an Award Agreement, the Company will refund to
the Participant the lesser of (i)&nbsp;the amount originally paid by the Participant for such shares and (ii)&nbsp;the Fair Market Value of such shares on the date of forfeiture. Without limiting <U>Section</U><U></U><U>&nbsp;8(a)</U>, by acceptance
of a Restricted Stock Award, the Participant shall be deemed to appoint, and does so appoint by execution of the Award Agreement, the Company and each of its authorized representatives as the Participant&#146;s <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> to effect the transfer of forfeited shares subject to the Restricted Stock Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Nontransferability</U>. Shares granted under any Restricted Stock Award may not be transferred, assigned or
subject to any encumbrance, pledge, or charge unless and until (i)&nbsp;the vesting conditions applicable to the Award have been achieved, and (ii)&nbsp;the other restrictions on transferability applicable to Common Stock set forth in the Plan, the
Award Agreement or otherwise have been satisfied. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Rights as a Stockholder</U>. Subject to the foregoing provisions of this Section&nbsp;8 and, unless
otherwise stated in the applicable Award Agreement, a Participant generally shall have the rights and privileges of a stockholder with respect to shares of Common Stock granted to the Participant under a Restricted Stock Award, including the right
to vote such </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
shares and the right to receive dividends and distributions with respect such shares. However, unless provided otherwise in an Award Agreement, all cash and stock dividends and distributions
shall be held back by&nbsp;the Company for the Participant&#146;s account until such time as the related portion of the Restricted Stock Award vests (at which time such dividends or distributions, as applicable, shall be released and paid) and if
such related portion of the Restricted Stock Award is forfeited, such dividends or distributions, as applicable, will be forfeited. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Section 83(b) Election</U>. If a Participant makes an election pursuant to Section&nbsp;83(b) of the Code
with respect to a Restricted Stock Award, the Participant shall file, within 30 days following the date of grant of the Award, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under
Section&nbsp;83 of the Code. The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant&#146;s making or refraining from making an election with respect to the Award under Section&nbsp;83(b)
of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Restricted Stock Unit Awards</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Grant of Restricted Stock Units</U>. An Award of hypothetical Common Stock units (&#147;Restricted Stock
Units&#148;) having a value equal to the Fair Market Value of an identical number of shares of Common Stock may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the number of
shares of Restricted Stock Units subject to the Award, the vesting and/or earnings conditions applicable to the Restricted Stock Units, the timing for settlement of the Restricted Stock Units and such other terms and conditions as the Committee, in
its sole discretion, shall determine. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of any such Award. A Participant shall have no
voting rights with respect to any Restricted Stock Units granted hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Vesting of Restricted Stock Units</U>. The Committee shall, in its sole discretion, provide in an Award
Agreement the time or times at which, or the conditions upon which, Restricted Stock Units shall vest and/or be settled. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#146;s continued Service as
of a specified date) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement
between a Participant and the Company, for the acceleration of vesting of any Restricted Stock Units upon a Participant&#146;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. If
the vesting requirements applicable to Restricted Stock Units are not satisfied, such units shall automatically be forfeited. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Dividend Equivalent Rights</U>. The Committee may permit Participants holding Restricted Stock Units to
receive Dividend Equivalent Rights on outstanding Restricted Stock Units if dividends are paid to stockholders on shares of Common Stock. If so permitted by the Committee, such Dividend Equivalent Rights may be paid in cash or shares of Common Stock
(in the sole discretion of the Committee), and will be payable to the Participant upon settlement of the Restricted Stock Units to which the Dividend Equivalent Rights relate and, to the extent such Restricted Stock Units are forfeited, the
Participant shall have no right to payment in respect of the Dividend Equivalent Rights. If the Committee permits Dividend Equivalent Rights to be made on Restricted Stock Units, the terms and conditions for such Dividend Equivalent Rights will be
set forth in the applicable Award Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Settlement</U>. At the time of settlement of a vested Restricted Stock Unit (which may be upon or
following vesting of the Award, as set forth in the Award Agreement), the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit and cash
equal to any Dividend Equivalents credited with respect to each such vested Restricted Stock Unit and any interest thereon (or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to such Dividend
Equivalents and the interest thereon, if any); <I>provided, however</I>, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of
delivering only shares of Common Stock for vested Restricted Stock Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date
on which the Restricted Stock Unit vested (or specified deferred settlement date, if later). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Performance Awards</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Types of Performance Awards</U>. In the discretion of the Committee, a Performance Award may be granted to
any Eligible Person as an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award, Other Stock-Based Award or Cash Award. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Terms of Performance Awards</U>. Performance Awards will be based on the attainment of Performance Goals
that are established by the Committee for the relevant Performance Period. Prior to the grant of any Performance Award, the Committee will determine and each Award Agreement shall set forth the terms of each Performance Award, including, without
limitation: (i)&nbsp;the nature, length and starting date of any Performance Period; (ii)&nbsp;the Performance Goals that shall be used to determine the time and extent to which a Performance Award has been earned; (iii)&nbsp;amount of any cash
bonus, or the number of shares of Common Stock deemed subject to a Performance Award, and (iv)&nbsp;the effect of a termination of Participant&#146;s Service on a Performance Award. Participants may participate simultaneously with respect to
Performance Awards that are subject to different Performance Periods and Performance Goals. A Performance Award may but need not require the Participant&#146;s completion of a specified period of Service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Determination of Achievement</U>. The Committee shall determine the extent to which a Performance Award has
been earned in its sole discretion, including the extent to which Performance Goals have been attained, and the degree of achievement between minimum and maximum levels. The Committee may reduce or waive any criteria with respect to a Performance
Goal, or adjust a Performance Goal (or method of calculating the attainment of a Performance Goal) to take into account unanticipated events, including changes in law and accounting or tax rules, as the Committee deems necessary or appropriate, or
to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships. The Committee may also adjust or eliminate the compensation or economic benefit due upon attainment of Performance Goals in its sole
discretion, subject to any limitations contained in the Award Agreement and compliance with Applicable Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Other Stock-Based Awards and Cash Awards</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Other Stock-Based Awards</U>. The Committee may grant, either alone or in tandem with other Awards, to any
Eligible Person an Other Stock-Based Award that is payable in, valued in whole or in part by reference to, or otherwise based or related to shares of Common Stock, including, but not limited to, shares of Common Stock awarded as a bonus or other
compensation which are issued without restrictions on transfer and other incidents of ownership and free from forfeiture conditions (other than those that generally apply to shares of Common Stock under the Plan). An Other Stock-Based Award shall be
evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Award, any payment required for such Award, any vesting conditions applicable to the Award and such other terms and conditions as the Committee, in its
sole discretion, shall determine. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Cash Awards</U>. The Committee may grant, to any Eligible Person, a Cash Award that is payable
contingent upon the attainment during a Performance Period of certain Performance Goals and/or such other terms as the Committee may determine (&#147;<U>Cash Award</U>&#148;). A Cash Award may also require the completion of a specified period of
Service. The degree to which Performance Goals applicable to a Cash Award have been attained will be conclusively determined by the Committee, in its sole discretion. The Committee may specify the form of payment of Cash Awards, which may be cash or
other property, or may provide for a Participant to have the option for his or her Cash Award, or such portion thereof as the Committee may specify, to be paid in whole or in part in cash or other property. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Forfeiture Events</U> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>General</U>. The Committee may specify in an Award Agreement that the Participant&#146;s rights, payments
and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events. Such events may include, without limitation, a termination of Service for Cause and/or
breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is materially detrimental to the business or reputation of the Company. The Committee shall have the
power to determine whether the Participant has been terminated for Cause and the date upon which such termination for Cause occurs. Any such determination shall be final, conclusive and binding upon the Participant. In addition, if the Company shall
reasonably determine that a Participant has committed or may have committed any act which could constitute the basis for a termination of such Participant&#146;s Service for Cause, the Committee may, subject to compliance with Applicable Law,
suspend the Participant&#146;s rights to exercise any Option or Stock Appreciation Right, receive any payment or vest in any right with respect to any Award pending a determination by the Company of whether an act has been committed which could
constitute the basis for a termination for Cause. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Right of Recapture</U>. Unless otherwise provided in an Award Agreement, if at any time within 1 year
after the date on which a Participant exercises an Option or Stock Appreciation Right or on which an another Award vests or becomes payable, or on which income otherwise is realized by a Participant in connection with an Award,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Participant&#146;s Service is terminated for Cause, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Committee determines in its sole discretion either that, (A)&nbsp;while in Service, the Participant had
engaged in an act which would have warranted termination for Cause, or (B)&nbsp;after termination of Service for any reason, the Participant has engaged in conduct that violates any continuing obligation or duty of the Participant in respect of the
Company, or any Affiliate, then any gain realized by the Participant from the exercise, vesting, payment or other realization of income by the Participant in connection with an Award, shall be paid by the Participant to the Company upon notice
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
from the Committee. Such gain shall be determined as of the date on which the gain is realized by the Participant, without regard to any subsequent change in the Fair Market Value of a share of
Common Stock. The Company shall have the right to offset such gain against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay or pursuant to any benefit plan or other compensatory arrangement), subject to
compliance with Section&nbsp;409A of the Code and other Applicable Law. The foregoing shall apply in addition to any other relief available to the Company or any of its Affiliates at law or otherwise and without limiting the ability of the Company
or any of its Affiliates to pursue the same. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Clawback/Recovery</U>. All Awards granted under the Plan will be subject to recoupment in accordance with
any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the Dodd-Frank Wall
Street Reform and Consumer Protection Act or other Applicable Law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement or compensation clawback policy as the Board determines necessary or
appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback
policy will be an event giving rise to a right to voluntarily terminate employment upon a &#147;resignation for good reason,&#148; or for a &#147;constructive termination&#148; or any similar term under any plan of or agreement with the Company or
any Affiliate. Without limiting the generality of the foregoing, any such clawback policy of the Company, whether required by applicable listing standards or law, or otherwise adopted by the Board in its discretion, may provide that if a
Participant, regardless of his or her position with the Company, receives compensation pursuant to an Award under the Plan based on financial statements that are subsequently required to be restated in a way that would decrease the value of such
compensation, the Participant will forfeit and repay to the Company the difference between what the Participant received and what the Participant should have received based on the accounting restatement. By accepting an Award hereunder, the
Participant acknowledges and agrees that any such policy shall apply to such Award, and all compensation payable pursuant to such Award shall be subject to forfeiture and repayment pursuant to the terms of such policy. Although not required to give
effect to the provisions of this Section&nbsp;12(c), the Committee may, as it deems appropriate, amend the Plan to reflect the terms of any such policy. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Change in Control</U></B>. Notwithstanding any provision of the Plan to the contrary, in the event
of a Change in Control, outstanding Awards under the Plan shall be subject to the agreement pursuant to which the Change in Control takes place (or to such treatment as the Committee otherwise determines), which need not treat all outstanding Awards
or Participants in an identical manner. Such agreement (or other treatment), without the Participant&#146;s consent, may provide for one or more of the following with respect to Awards outstanding as of or immediately prior to the effective date of
the Change in Control: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The continuation of any outstanding Awards by the Company (if the Company is the surviving entity);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The assumption of any outstanding Awards by the acquirer or surviving entity or its parent or subsidiary in a
manner that complies with Sections 424(a) and 409A of the Code (as applicable), or the substitution by the successor or acquiring entity or its parent or subsidiary of equivalent awards with substantially the same terms for such outstanding Award in
a manner that complies with Sections 424(a) and 409A of the Code (as applicable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Full or partial acceleration of vesting and/or, if applicable, exercisability, of any Awards, and, in the case
of Options or Stock Appreciation Rights, followed by the cancellation of such Options or Stock Appreciation Rights, if not exercised within a time period prior to the Change in Control, as specified by the Committee. The full or partial
exercisability of such Awards and full or partial vesting of any Awards may be contingent on the closing of such Change in Control. Any exercise of Options or Stock Appreciation Rights during such period may be contingent on the closing of such
Change in Control; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to Performance Awards, the cessation, upon the date of the Change in Control, of any incomplete
Performance Periods applicable to such Awards, with the Committee determining the extent to which the Performance Goals applicable to such Awards have been attained as of the date of the Change in Control based on such audited or unaudited financial
information then available as the Committee deems appropriate, and partial or full payment to the Participant in respect of such Awards based on such determination by the Committee, or, if not determinable, with the assumption that the applicable
&#147;target&#148; level of performance has been attained, or on such other basis determined by the Committee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The settlement of Awards (whether or not then vested or exercisable) in cash, cash equivalents, or securities
of the successor entity (or its parent, if any) with a fair market value (as determined by the Committee) equal to the required amount provided in the agreement pursuant to which the Change in Control occurs, followed by the cancellation of such
Awards; provided however, that such Award may be cancelled without consideration if such Award has no value, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
as determined by the Committee in its sole discretion. Subject to compliance with Section&nbsp;409A of the Code, such payment may be made in installments and may be deferred until the date or
dates the Award would have become exercisable or vested. Such payment may be subject to vesting based on the Participant&#146;s continuous Service, provided that the vesting schedule shall not be less favorable to the Participant than the schedule
under which the Award would have become vested or exercisable. For purposes of this paragraph, the Fair Market Value of any security shall be determined without regard to any vesting conditions that may apply to such security. Further, subject to
compliance with Section&nbsp;409A of the Code, the Participant may be required to bear his or her pro rata share of any post-closing indemnity obligations with respect to the Award and settlement of the Award may be subject to the same post-closing
purchase price adjustments, escrow terms, offset rights, holdback terms, and similar conditions as the holders of Common Stock. Without limitation of the foregoing, in the case of Options and/or Stock Appreciation Rights, such settlement may, at the
discretion of the Committee, include payment to one or more Participants holding such Options or Stock Appreciation Rights equal to the excess, if any, of (i)&nbsp;the Fair Market Value of the shares subject to each such Option or Stock Appreciation
Right (whether or not such Option or Stock Appreciation Right is then vested or exercisable) as of the closing date of such Change in Control over (ii)&nbsp;aggregate Exercise Price or Base Price of such Option or Stock Appreciation Right. With
respect to any or every Option or Stock Appreciation Right that has a per share Exercise Price or Base Price that equals or exceeds the Fair Market Value per share of Common Stock as of the closing of the Change in Control, the Committee, in its
discretion, may provide for the cancellation of such Option or Stock Appreciation Right without any payment to the Participant therefor; and/or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The cancellation of unvested Awards (or portion thereof) in exchange for no consideration. Unless otherwise
determined by the Committee and evidenced in an Award Agreement (or as otherwise determined by the Committee), in the event of a Change in Control and either (i)&nbsp;an outstanding Award is not assumed or substituted in connection with the Change
in Control, or (ii)&nbsp;an outstanding Award is assumed or substituted in connection therewith but the Participant&#146;s Service is terminated by the Company (or its successor or affiliate) without Cause within twelve (12)&nbsp;months after the
Change in Control, then: (A)&nbsp;any unvested or unexercisable portion of any Award carrying a right to exercise shall become fully vested and exercisable, and (B)&nbsp;the restrictions (including exercise restrictions), deferral limitations,
payment conditions and forfeiture conditions applicable to an Award granted will lapse and such Award will be deemed fully vested, and any performance conditions on the Award will be deemed achieved based on actual performance levels as determined
by the Committee. For purposes of the preceding sentence, an Award shall be considered to be assumed or substituted for if, following the Change in Control, the Award remains subject to the same terms and conditions that were applicable to the Award
immediately prior to the Change in Control except that, if the Award related to shares of Common Stock, the award instead confers the right to receive, or otherwise relates to, common stock of the acquiring or surviving entity (with adjustment to
such number of shares subject to the Award as determined by the Committee). For the avoidance of doubt, the Committee may accelerate the vesting of or waive restrictions on awards in whole or in part at any time, for any reason (subject to
compliance with Section&nbsp;409A of the Code, to the extent applicable to the Award). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>General Provisions</U> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Additional Documentation</U>. The Company may, at any time, require a Participant to execute any additional
documents or instruments necessary or desirable, as determined by the Committee, to carry out the purposes or intent of any Award and/or to facilitate compliance with securities, tax and/or other regulatory requirements. Any such additional
documents or instructions may, but need not be, appended to an Award Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Restrictions on Transfer of Awards</U>. Except as expressly provided in the Plan or an applicable Award
Agreement, or otherwise determined by the Committee, no Participant may sell, transfer, assign, pledge, donate or otherwise dispose of (including any transfer by operation of law or involuntary transfer) Awards or any interest therein for any reason
during the Participant&#146;s lifetime, and any attempt to do so shall be void and shall result in the relevant Award being forfeited. The Committee may grant Awards (except Incentive Stock Options) that are transferable by the Participant during
his or her lifetime, but such Awards shall be transferable only to the extent specifically provided in such Participant&#146;s Award Agreement. In the event of the death of a Participant, an Award may be transferred by will or the laws of descent or
distribution. The transferee of the Participant shall, in all cases, be subject to the provisions of the Award Agreement and the terms and conditions of this Plan. Unless otherwise determined by the Committee, an Option or Stock Appreciation Right
may be exercised during the lifetime of the Participant, only by the Participant or, during the period the Participant is under a legal disability, by the Participant&#146;s guardian or legal representative. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Rights as a Stockholder</U>. A Participant shall have no rights as a holder of shares of Common Stock
with respect to any unissued securities covered by an Award until the date the Participant becomes the holder of record of such securities (except for any Dividend Equivalent Rights permitted by an applicable Award Agreement). Except as otherwise
provided for in the Plan or an Award Agreement, after shares of Common Stock are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such shares, including the right to vote and
receive dividends or other distributions. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Prohibition Against Exchange and Buyout of Awards</U>. Notwithstanding any provision of the Plan to the
contrary, except in connection with a corporate transaction involving the Company (including, without limitation, a Change in Control or any transaction or event described in <U>Section</U><U></U><U>&nbsp;4(d)</U>), the Committee shall not, without
the approval of the Company&#146;s stockholders, (i)&nbsp;reduce the Exercise Price of an Option or reduce the Base Price of a Stock Appreciation Right after it is granted, (ii)&nbsp;cancel any outstanding Option or Stock Appreciation Right in
exchange for another Award, or Option or Stock Appreciation Right with an Exercise Price or Base Price, as applicable, that is less than the Exercise Price or Base Price of the original Option or Stock Appreciation Right, (iii)&nbsp;cancel an
outstanding Option or Stock Appreciation Right when the Exercise Price or Base Price, as applicable, exceeds the Fair Market Value of a share of the Common Stock in exchange for cash or other securities, or (iv)&nbsp;take any other action with
respect to an Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities market on which the Common Stock is traded. Any amendment or repeal of this
<U>Section</U><U></U><U>&nbsp;14(d)</U> shall require the approval of the stockholders of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Deferrals of Payment</U>. To the extent permitted by Applicable Law, the Committee, in its sole discretion,
may determine that the delivery of shares of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award shall or may be deferred and may establish programs and procedures for deferral elections to
be made by Participants. Deferrals by Participants (or deferred settlement or payment required by the Committee) will be made in accordance with Section&nbsp;409A of the Code, if applicable, and any other Applicable Law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Acceleration of Exercisability and Vesting</U>. The Committee shall have the power and authority to
accelerate the time at which an Award or any part thereof may be exercised or the time at which an Award or any part thereof will vest, notwithstanding the provisions in the Award stating the time at which an award may be exercised or the time at
which it will vest. Any such acceleration shall be subject to compliance with Section&nbsp;409A of the Code, to the extent applicable to the Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Corporate Action Constituting Grant of Awards</U>. Corporate action constituting a grant by the Company of
an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually
received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., Exercise Price, Base Price, vesting schedule
or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the
Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Securities Law Compliance</U>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>General</U>. No shares of Common Stock shall be purchased, sold or otherwise issued pursuant to any Award
unless and until (A)&nbsp;any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Committee and its counsel and (B)&nbsp;if required to do so by the Committee, the
Participant has executed and delivered to the Company a letter of investment intent in such form and containing such provisions as the Committee may require in its sole discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Section 16</U>. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that
satisfies, the applicable requirements of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> as promulgated under Section&nbsp;16 of the Exchange Act so that Participants will be entitled to the benefit of Rule
<FONT STYLE="white-space:nowrap">16b-3,</FONT> or any other rule promulgated under Section&nbsp;16 of the Exchange Act, and will not be subject to short-swing liability under Section&nbsp;16 of the Exchange Act. Accordingly, if the operation of any
provision of the Plan would conflict with the intent expressed in this subsection, such provision to the extent possible shall be interpreted and/or deemed amended so as to avoid such conflict. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">I.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Tax Withholding</U>. All Awards (including the issuance or vesting of shares or payment of cash
pursuant to an Award) shall be subject to all applicable tax withholding. Prior to the delivery of any shares of Common Stock or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholdings are due, the Company will
have the power and right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, or other taxes (including
the Participant&#146;s FICA obligation) required to be withheld with respect to such Award. The Committee, or its delegate(s), as permitted by Applicable Law, in its sole discretion and pursuant to such procedures as it may specify from time to time
and subject to limitations of Applicable Law, may require or permit a Participant to satisfy any applicable tax withholding obligations, in whole or in part by (without limitation)&nbsp;(A) requiring the Participant to make a cash payment,
(B)&nbsp;withholding from the Participant&#146;s wages or other cash compensation paid to the Participant by the Company or any Affiliate; (C)&nbsp;withholding from the shares of Common Stock otherwise issuable pursuant to an Award;
(D)&nbsp;permitting the Participant </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
to deliver to the Company already-owned shares of Common Stock, (E)&nbsp;withholding from the proceeds of the sale of otherwise deliverable shares of Common Stock acquired pursuant to an Award
either through a voluntary sale or through a mandatory sale arranged by the Company or (F)&nbsp;such other means as the Committee shall deem appropriate. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">j.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Section 409A Compliance</U>. It is intended that this Plan and any Awards will comply with, or avoid
application of, the provisions of Section&nbsp;409A of the Code, and they shall be interpreted and construed on a basis consistent with that intent. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically
provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#147;nonqualified deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for
purposes of Section&nbsp;409A of the Code, no distribution or payment of any amount that is due because of a &#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code without regard to alternative definitions thereunder) will
be issued or paid before the date that is six months following the date of such Participant&#146;s &#147;separation from service&#148; or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a
manner that complies with Section&nbsp;409A of the Code, and any amounts so deferred will be paid in a lump sum (without interest) on the day after such six month period elapses, with the balance paid thereafter on the original schedule.
Notwithstanding the foregoing, the Company and its Affiliates and their respective employees, officers and directors shall have no liability whatsoever to a Participant nor any other Person (i)&nbsp;if an Award that is intended to be exempt from, or
compliant with, Section&nbsp;409A of the Code is not so exempt or compliant, or (ii)&nbsp;in respect of any decision to take action to attempt to comply with Section&nbsp;409A of the Code, any omission to take such action or for the failure of any
action taken by the Company to so comply. Notwithstanding the foregoing, in the sole discretion of the Committee, the Company may, but is under no obligation to, agree to pay all or a portion of the individual tax liability of one or more
Participants whose awards do not satisfy the conditions for exemption under Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">k.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Obligation to Notify or Minimize Taxes</U>. The Company shall have no duty or obligation to any
Participant to advise such holder as to the time or manner of exercising an Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise any Participant of a pending termination or expiration of any Award or a
possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of any Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">l.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unfunded Plan</U>. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by
the Company to discharge its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a Participant under the Plan shall be those of a
general unsecured creditor of the Company, and neither a Participant nor the Participant&#146;s permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan. The Plan is not intended to be a plan
that is subject to the Employee Retirement Income Security Act of 1974, as amended, and shall be interpreted accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">m.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Stop Transfer Orders</U>. All certificates for shares of Common Stock delivered under the Plan
pursuant to any Award shall be subject to such stop-transfer orders and other restrictions as the Committee may deem advisable under Applicable Law, and the Committee may cause a legend or legends to be put on any such certificates to make
appropriate reference to such restrictions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">n.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Other Compensation and Benefit Plans</U>. The adoption of the Plan shall not affect any other share
incentive or other compensation plans in effect for the Company or any of its Affiliates, nor shall the Plan preclude the Company from establishing any other forms of share incentive or other compensation or benefit program for employees of the
Company or any of its Affiliates. The amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is
entitled under any other compensation or benefit plan or program of the Company or an Affiliate, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of any such plan.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">o.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Plan Binding on Transferees</U>. The Plan shall be binding upon the Company, its successors,
transferees and assigns, and the Participant, the Participant&#146;s executor, administrator and permitted transferees and beneficiaries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">p.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Severability</U>. Whenever possible, each provision of this Plan will be interpreted in such manner
as to be effective and valid under Applicable Law, but if any provision of this Plan is held to be invalid, illegal or unenforceable in any respect under any Applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability
will not affect any other provision or the enforceability of this Plan in any other jurisdiction, but this Plan will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been
contained herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">q.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Foreign Award Recipients</U>. Notwithstanding any provision of the Plan to the contrary, in order to
comply with the laws and practices in other countries in which the Company and its Affiliates operate or have Employees or other Eligible Persons, the Committee, in its sole discretion, will have the power and authority to: (i)&nbsp;determine which
Affiliates will </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
be covered by the Plan; (ii)&nbsp;determine which individuals outside the United States are eligible to participate in the Plan; (iii)&nbsp;modify the terms and conditions of any Award granted to
individuals outside the United States or foreign nationals to comply with applicable foreign laws, policies, customs and practices; (iv)&nbsp;establish subplans and modify exercise procedures and other terms and procedures, to the extent the
Committee determines such actions to be necessary or advisable (and such subplans and/or modifications will be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications will increase the share limitations
contained in Section&nbsp;4(a); and (v)&nbsp;take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.
Notwithstanding the foregoing, the Committee may not take any actions under the Plan, and no Awards will be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United
States governing statute or law. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">r.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>No Continued Service Rights</U>. Neither the Plan nor any Award granted hereunder shall confer on any
Participant any right to continuation of the Participant&#146;s employment or other service relationship with the Company or its Affiliates, nor shall it interfere in any way with such Participant&#146;s right or the right of the Company or its
Affiliates to terminate such relationship, with or without Cause. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">s.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U></U><U>Governing Law</U>. All issues concerning this Plan will be governed by, and construed in accordance
with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the law of any jurisdiction
other than the State of Delaware. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">t.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Captions</U>. The captions in the Plan are for convenience of reference only, and are not intended to
narrow, limit or affect the substance or interpretation of the provisions contained herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Amendment and Termination</U>. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Amendment</U>. The Board at any time, and from time to time, may amend the Plan in any respect that it deems
necessary or advisable, subject to the limitations of Applicable Law and this <U>Section</U><U></U><U>&nbsp;15</U>. If required by Applicable Law, the Company will seek stockholder approval of any amendment of the Plan that (i)&nbsp;materially
increases the number of shares of Common Stock available for issuance under the Plan (except as provided in <U>Section</U><U></U><U>&nbsp;4(d)</U> relating to adjustments upon changes in Common Stock), (ii) materially expands the class of
individuals eligible to receive Awards under the Plan, (iii)&nbsp;materially increases the benefits accruing to Participants under the Plan, (iv)&nbsp;materially reduces the price at which Common Stock may be issued or purchased under the Plan,
(v)&nbsp;materially extends the term of the Plan, (vi)&nbsp;materially expands the types of Awards available for issuance under the Plan, or (vii)&nbsp;as otherwise required by Applicable Law. The Committee at any time, and from time to time, may
amend the terms of any one or more Awards, subject to the limitations of this <U>Section</U><U></U><U>&nbsp;15</U>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Termination</U>. The Plan shall terminate automatically on the 10th anniversary of the Effective Date. The
Board at any earlier time may suspend or terminate the Plan. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated, but Awards previously granted may extend beyond suspension or termination of the Plan.
Termination of the Plan shall not affect the Board&#146;s or the Committee&#146;s ability to exercise the powers granted to it under the Plan with respect to Awards granted or awarded under the Plan prior to the date of such termination.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Impairment</U>. No amendment, suspension or termination of the Plan or any Award pursuant to this
<U>Section</U><U></U><U>&nbsp;15</U> may materially impair a Participant&#146;s rights under any outstanding Award, except with the written consent of the affected Participant or as may otherwise be expressly permitted in the Plan. Notwithstanding
the foregoing, subject to the limitations of Applicable Law, if any, the Committee may amend the terms of any one or more Awards without the affected Participant&#146;s consent (i)&nbsp;to maintain the qualified status of the Award as an Incentive
Stock Option under Section&nbsp;422 of the Code; (ii)&nbsp;to clarify the manner of exemption from, or to bring the Award into compliance with, Section&nbsp;409A of the Code; or (iii)&nbsp;to facilitate compliance with other Applicable Laws.
</P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d837937dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath&#146;s Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEW YORK, May&nbsp;28, 2024 Delcath Systems, Inc. (Nasdaq: DCTH) (the &#147;Company&#148; or &#147;Delcath&#148;), an interventional oncology company focused
on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr.&nbsp;Bridget Martell to the Company&#146;s Board of Directors effective May&nbsp;23, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased to welcome Dr.&nbsp;Martell to the Delcath Board,&#148; said John Sylvester, Chairman of the Delcath Board of Directors.
&#147;Dr.&nbsp;Martell&#146;s extensive experience serving both in senior management roles and as a director at multiple biotechnology companies, as well as her expertise in oncology clinical development, will be a great asset to Delcath as we
strive to achieve our mission of improving patient outcomes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Martell is currently an independent director at the publicly traded companies
Aligos Therapeutics (Nasdaq:ALGS) and Achieve Life Sciences (Nasdaq: ACHV). She was a director of POINT Biopharma Global, Inc. (Nasdaq: PNT), a cancer treatment biotechnology company, from June 2023 until its acquisition by Eli Lilly and Company in
December 2023 and Ayala Pharmaceuticals, another oncology focused company whose assets were sold to Immunome in March of 2024. She recently joined Two Bear Capital as a Biotechnology Operating Partner. Prior to this she was the founder and managing
partner of BAM Consultants a biotechnology focused consulting practice and during that tenure has served in a full time capacity as a <FONT STYLE="white-space:nowrap">C-suite</FONT> executive including as President and Chief Executive Officer of
Artizan Biosciences, Inc., a privately held biotechnology company, and as a Chief Medical Officer for various early-stage and <FONT STYLE="white-space:nowrap">mid-stage</FONT> private and public biotechnology companies </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Martell holds a B.S. in microbiology from Cornell University, an M.A. in Molecular Immunology from Boston University and an M.D. from Chicago Medical
School. She completed her internship and residency in internal medicine and was an internal medicine chief resident and RWJ Faculty Clinical Scholar at Yale University. Dr.&nbsp;Martell is board certified in both Internal and Addiction Medicine.
Dr.&nbsp;Martell was a Teaching Attending and Clinical Associate Professor at Yale from 2005 to 2020 and has continued her engagement at Yale as an Entrepreneur In Residence at Yale Ventures since 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am excited to be joining Delcath&#146;s Board of Directors at this crucial time in the Company&#146;s growth and evolution,&#148; said
Dr.&nbsp;Martell. &#147;I look forward to supporting the Delcath team both in its near-term commercial goals and longer-term clinical development strategy.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company&#146;s proprietary
products, HEPZATO KIT<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Hepatic Delivery System for Melphalan
percutaneous hepatic perfusion (PHP), are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, HEPZATO KIT is considered a combination drug and device product and is regulated and approved for sale as a drug by the FDA. HEPZATO KIT
is comprised of the chemotherapeutic drug melphalan and Delcath&#146;s proprietary Hepatic Delivery System (HDS). The HDS is used to surgically isolate the liver while simultaneously filtrating hepatic venous blood during melphalan infusion and
washout. The use of the HDS results in loco-regional delivery of a relatively high melphalan dose, which can potentially induce a clinically meaningful tumor response with minimal hepatotoxicity and reduce systemic exposure. HEPZATO KIT is approved
in the United States as a liver-directed treatment for adult patients with metastatic uveal melanoma (mUM) with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the
bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation. Please see the full <U>Prescribing Information</U>, including BOXED WARNING for the HEPZATO KIT. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Europe, the device-only configuration of the HDS is regulated as a Class&nbsp;III medical device and is
approved for sale under the trade name CHEMOSAT Hepatic Delivery System for Melphalan, or CHEMOSAT, where it has been used in the conduct of percutaneous hepatic perfusion procedures at major medical centers to treat a wide range of cancers of the
liver. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westwicke
Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@delcath.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dcth-20240523.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/29/2024 9:47:05 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:dcth="http://www.delcath.com/20240523"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.delcath.com/20240523"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20240523_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20240523_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>dcth-20240523_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/29/2024 9:47:05 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>dcth-20240523_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/29/2024 9:47:05 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dcth-20240523.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139923919287264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000872912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 23,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Delcath Systems, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1245881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">566 Queensbury Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Queensbury<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">489-2100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DCTH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M!_A^I91];[C#:_G;P^A?4$L#!!0    ( ,^ O5B?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M6@L5!K!O<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( ,^ O5@'04UB@0   +$    0
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MB@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #/@+U8EXJ[',     3 @
M"P              @ %F#P  7W)E;',O+G)E;'-02P$"% ,4    " #/@+U8
M'#AEZC\!   \ @  #P              @ %/$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ SX"]6"0>FZ*M    ^ $  !H              ( !NQ$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ SX"]6&60
M>9(9 0  SP,  !,              ( !H!(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  ZA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d837937d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  d837937d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d837937d8k.htm">d837937d8k.htm</File>
    <File>dcth-20240523.xsd</File>
    <File>dcth-20240523_lab.xml</File>
    <File>dcth-20240523_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d837937d8k.htm": {
   "nsprefix": "dcth",
   "nsuri": "http://www.delcath.com/20240523",
   "dts": {
    "inline": {
     "local": [
      "d837937d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "dcth-20240523.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dcth-20240523_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dcth-20240523_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d837937d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d837937d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.delcath.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-149142-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-149142-xbrl.zip
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M:<AD3V@Z/^6$-?+L^-F0RTF"B2M$IJPX$6;TFG*#NRBCJSLIA;--S5!^%V[
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MH1)8*)EX6\2U:@[ ;X(,7VL=?UD@>"O6:!9O^^E#7=?.S@60P6;>T'48<22
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MN5V\HZ4B[$9=+.'TK6 72Y[)M;Z#AX_NG4,7SM1OL"E!0JTH4\@WSNP%QH6
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M6Z-K*#!#&-L  T/V&1@)O,'Q!YZY47-M]"X &?GOI/?AE(]*J)M:#Q+"91+
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MBTEWPML71UF/%53AD."DW3O\V779*H077)0NH79%*3IF? +E]!H4:V 5B?^
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M0550S%3PI=071!.YK(KNRM=L8.Q'3O6RTG1+5/JY4&XR*_MW3@,=4)"Y\UG
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MD!V_G\^D 9XQR@*&#[9\D=;,D770_GZM]M=]#-K?ZY8H7*L&30VMU,>DU*(
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MI !ZL65!=N-G(DPXV$DKZ*@U D&",@(F8W$K4IW3L7ML(;%O"M>R.2$1(BP
MLD[B(+M>L\Z0382T*)&0P'0! Z2U #IY2&:YT=[('*#UR"L<A<>V2L\33A[F
MSZ>!R3T8($.BPACHDBY#;L8B%_@&Y38=3!'/BVDJ(ZQSAL> U\J[]5H7)4!;
M-H%K>2X*9*1=447W_-WUK@];MW3+N9P)=AWYN*_7L>[9X.-NBUWCJ,5VA.&[
M\6AX.6&G4N<)!PS9NU1/>7J7E<:7$^*8D@XVF.,A7"SWV,SHC+TOE* \?<X*
M<!)\XG!X]'<AK22*8M,EZZ<26J=IX)V2#."L>JTG(I%-<987X*U<\I2SL5<S
M\K[@*0%0 =A8MP);27,KVELD&G#TX"(\(8^M3GT2#[.L4)3%P"H"%R7DD$ L
MY"PX*<3O,Q@- B<+S4X%-^R,Y]+Q-*3+Z98'1H _, @HCH$$)4R+C0WEF^<%
MH,*64:# ST";,53WG$OYB'WU6AXV^D+7O8!3E$46<D7>N^/OM:E^C<\ P\&6
MR'L2&A>&WKF$D"94 =L3G$V4@%VPFK-90:0%/".V.8^D6P:SVF]'P$75EB32
MB:;%Y^)8Z06PV.B<-6V!M^U]6MA!XHNH\#0M5906,9T+06,CK/2H]P$&3F>L
MOUHZFLUDY$T%U$$;WY I\*<M(1Q02+A#=;KE2*PE2 :Q>P1U*PH+YUR(V)-.
M=<H,8;CEB$8!JN0F7391Y.;!4S\T-Y-Q6%X97*KD=X<,?HPD__DJ=8]^$B#<
M@[-UW:(X9S(R&NH%U%!RGFFC:.4'124=&>G]QRY:7;_A C4A*E* /23)>N.I
MM@[)N]X7W$Y;>ZU2=@*_SW45@'KM.DJT3D-6D5M2X8 _REK?LRB;R-R+*=$2
M$0>4GR& &<E!"OHEGL(>^C#R0=_"V]7->_:6PPYH>5;5(%*&#$-.?.(H;6M+
M6O?+.3)VZ@MQ1&5M)D/:^%HZK#3PY!1#"\]J%Z4^J-;WI 7ZG0BJ8\B/KD-2
MADRAY*@4[%JK(TG8&AL]$WA:*^O]>W1P\(((!51UX+=24H,#0 !%Z5>AYE5Y
MK[8&O_45R#M'81*HH4/%KDJ/B]6ZC]@$I@!-2'I]='#X\E]KM(:,9Z 2T%!H
ML] =$/F2BW[<V?MR2H77%'!?R6I2/=1GSHU>4(,!WXE;G184N<TN[7[L6JS2
M,-7Z"W')@A2 CK9 RVM<(-IU_^8$3*F:+BI]"IS3!&0R2H%,&*_C7*.(>3U2
MK>:B6O! O\30!@$3\^5F3_-82%X]T4C6G:*3>GADV6.#_OBO[F3$_AA. H '
M_8O1=7?RKXQ8#X]1TO[$(,1^8@[R@T\U#;6H(:ND59!""XJ]V&&6J.%&QT7D
M[):3VM<?5NY8V_KRQ;,3=DOL@H W_<Q_#"_YC'CQ_*2]CUT=MC,0^3<.M.UD
M(D6KEG*UZPO:4'T6GGCVL<*K"L^0LLO2-;M;L?E9'8R85RH\(M]K<5$I!=.!
M[ +MBJ RFY1[\')6^'9]9SP84RN)5B0&]<Q5.4/&&2!/$Q%+Y#QIQM2S18G(
M?'/'\V4U6(5 H$*GPE,>AI>44L]Z97 4)A!MJ=,)W4!)I3$CFBN'25LU1F@G
M!V.*7"3P1OP+-#<,D$/-(9VN 2ZQ#1(_.:"=@[8&*SC!;"H5][4E-D6H%> %
MZO%*F/E7V(=@H6238&][3E,1'BA MJH 009:;U+C;0_5?N/P>LV?CG%*^OP(
M$^E&&'S;'42L<.@/N\/.&\GP*&YV!KWKW9!*^(WT+\KA&N&;$Q+1[DGTZE0)
M[X;>RLPWQ80R+)O)U)5]=P4YY#\A< JZ7C7":YVE*O$(Y>LUU.4$1!>4@1:5
MY:07*B%.LL3BJ8YT$TX.M!)7]F QQS+HB6=J40'@C:,(RGND-N8+$ C+T22"
MFH)Y"O&C";AB?+S+!*>"A\:<N2)#[*!!#D1@;I @/,J3#,=[.[737V54-6$
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MW-\A!GACU/N$E_ZO6_\%4$L#!!0    ( ,^ O5A&KICD.0,  $D+   1
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MSF15C".?B"8/-U,M$J7G)+>:V&6)Q"G%3@LU9U$'^G?<'8PKA)>8%7!&S32
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MZX1AA^W*&VSN'##&-)Y+*Z\I+Z2\3\?F1^_8# "]XBDZN<4+V4LA'8C+3^O
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M#4 L^0M02P$"% ,4    " #/@+U89K=)$HP7  #NH   #@
M@ $     9#@S-SDS-V0X:RYH=&U02P$"% ,4    " #/@+U8 N?,/]MN  !R
MD0( $0              @ &X%P  9#@S-SDS-V1E>#$P,2YH=&U02P$"% ,4
M    " #/@+U8L\#[(5 *  #D&@  $0              @ '"A@  9#@S-SDS
M-V1E>#DY,2YH=&U02P$"% ,4    " #/@+U81JZ8Y#D#  !)"P  $0
M        @ %!D0  9&-T:"TR,#(T,#4R,RYX<V102P$"% ,4    " #/@+U8
M7>F+&& &  "^0P  %0              @ &IE   9&-T:"TR,#(T,#4R,U]L
M86(N>&UL4$L! A0#%     @ SX"]6)>@&7*Y!   >BH  !4
M ( !/)L  &1C=&@M,C R-# U,C-?<')E+GAM;%!+!08     !@ & '\!   H
%H      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d837937d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dcth-20240523.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-23_to_2024-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-23_to_2024-05-23"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-458">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-23_to_2024-05-23"
      id="Hidden_dei_EntityCentralIndexKey">0000872912</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-469">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-470">2024-05-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-471">Delcath Systems, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-472">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-473">001-16133</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-474">06-1245881</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-475">566 Queensbury Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-476">Queensbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-477">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-478">12804</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-479">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-480">489-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-481">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-482">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-483">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-484">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-485">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-486">DCTH</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-487">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
